Shares in Brighton Pier (LON: PIER) rebounded 114.8% to 14.5p following the announcement of plans to ask shareholders for approval for an exit from AIM. It costs up to £300,000/year to be on the junior market and there is a lack of liquidity. It is difficult to raise significant amounts of money. There are plans to arrange a refinancing with two major shareholders. The leisure group intends to secure a matched bargain facility. The share price was 17.75p before the announcement.
Respiratory drugs developer Synairgen (LON: SNG) says that TFG Asset Management says it will waive its right of refusal on transfers of more than one million shares up until any further fundraising. TFG owns 86.9% of the company. The AIM admission will be cancelled on 9 April. An Asset Match facility has been secured for two years. The share price recovered 17% to 1.1p.
Strategic Minerals (LON: SML) generated revenues of $1.18m in the first quarter of 2025, which is year-on-year growth of 41%, from the Cobre magnetite operation in New Mexico. The group had $530,000 in the bank. The share price increased 6.67% to 0.4p.
Shares in Zinnwald Lithium (LON: ZNWD) continue to rise following yesterday’s announcement that the Saxony state government has recognised the company’s eponymous lithium project as a project of outstanding importance. The company recently published a pre-feasibility study showing a pre-tax NPV of €3.3bn with a mine life of 40 years. The share price rose 5.93% to 6.25p.
Cambridge Cognition (LON: COG) is providing digital cognitive and voice assessments for two phase 3 clinical trials in adolescents with clinical depressive. The combined value of the contracts, which last until 2027 and 2029 respectively, is £1.2m. This will help Cambridge Cognition to meet 2025 revenue expectations of £12.5m, which would return the company to profit. The share price improved 4.17% to 37.5p.
FALLERS
Oracle Power (LON: ORCP) says assay results for five holes from the Northern Zone gold project in Western Australia and four have highlighted results. These confirm and enlarge the shallow gold mineralisation. Samples from four other holes are still be analysed and reported on. The share price declined 11.9% to 0.0185p.
Cancer treatments developer ValiRx (LON: VAL) has terminated its exclusivity agreement with TheoremRx Inc and ValiRx will move the VAL201 prospect to a prostate cancer focused special purpose vehicle. There is interest from a consortium and charities regarding possible support for development. The share price fell 10.5% to 0.425p.
K3 Technology (LON: KBT) intends to return £29m – equivalent to 64.8p/share – to shareholders via tender following a recent disposal and it is consulting with shareholders about whether to remain on AIM. The software company will still have £6m in cash and remaining software businesses that are a Microsoft Dynamics fashion industry partner and a supplier of software to IKEA. The share price slipped 6.32% to 89p.
Ex-dividends
Caledonia Mining Corporation (LON: CMCL) is paying a dividend of 14 cents/share and the share price rose 50p to 925p.
IDOX (LON: IDOX) is paying a final dividend of 0.7p/share and the share price declined 1.8p to 55.8p.
Personal Group Holdings (LON: PGH) is paying a final dividend of 10p/share and the share price fell 16p to 233p.
Quartix Holdings (LON: QTX) is paying a final dividend of 3p/share and the share price slipped 4p to 193p.
Real Estate Investors (LON: RLE) is paying a dividend of 0.4p/share and the share price is unchanged at 30p.